Cryptocurrencies
Biogen Stock Leaps, Eli Lilly Gains As Roche Alzheimer’s Drug Trial Falls Short
“While the (trial) results are not what we hoped, we are proud to have delivered a high quality, clear and comprehensive Alzheimer’s dataset to the field,” Roche said. Biogen (BIIB) – Get Free Report shares surged Read more…